Methyl 4-(3-amino-5-methyl-6-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-2-yl)benzoate

ID: ALA5172594

Chembl Id: CHEMBL5172594

PubChem CID: 168271162

Max Phase: Preclinical

Molecular Formula: C15H16N4O3

Molecular Weight: 300.32

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(-n2nc3c(c2N)CC(C)C(=O)N3)cc1

Standard InChI:  InChI=1S/C15H16N4O3/c1-8-7-11-12(16)19(18-13(11)17-14(8)20)10-5-3-9(4-6-10)15(21)22-2/h3-6,8H,7,16H2,1-2H3,(H,17,18,20)

Standard InChI Key:  LBMJPXOEEWILCO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5172594

    ---

Associated Targets(Human)

MKNK2 Tchem MAP kinase-interacting serine/threonine-protein kinase 1/2 (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 300.32Molecular Weight (Monoisotopic): 300.1222AlogP: 1.37#Rotatable Bonds: 2
Polar Surface Area: 99.24Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.19CX Basic pKa: 1.92CX LogP: 2.00CX LogD: 2.00
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.82Np Likeness Score: -0.54

References

1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S..  (2022)  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.,  65  (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941]

Source